Literature DB >> 20132090

When urine is no longer beneficial: renal artery embolisation in severe nephrotic syndrome secondary to amyloidosis.

Yalcin Solak1, Ilker Polat, Huseyin Atalay, Suleyman Turk.   

Abstract

Renal artery embolisation (RAE) is an interventional radiology procedure which is used to embolise small branches of renal artery. It is mainly used for urologic purposes, i.e., vascular malformations, angiomyolipomas and renal tumours not amenable to surgical resection. Bilateral RAE can be performed via using absolute ethanol, polyvinyl alcohol or microparticles. After RAE, patients may experience post-embolisation syndrome which is usually self-limited. Use of this procedure for refractory nephrotic syndrome has been rarely defined in the literature to date. Here, we describe a patient who had nephrotic syndrome due to secondary systemic amyloidosis. The patient presented with severe proteinuria (33 g per day), hypoalbuminaemia and anasarca oedema. We applied bilateral RAE with microparticles. We did not observe any complications associated with the procedure. Protein excretion, laboratory values and clinical signs returned to normal.

Entities:  

Mesh:

Year:  2010        PMID: 20132090     DOI: 10.3109/13506121003619336

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  3 in total

1.  Renal ablation using bilateral ureteral ligation for nephrotic syndrome due to renal amyloidosis.

Authors:  Mira T Keddis; Mark D Stegall; Stephen C Textor
Journal:  Clin Kidney J       Date:  2012-02-22

2.  Characteristics of ischemic stroke and intracranial hemorrhage in patients with nephrotic syndrome.

Authors:  Wen-Yi Huang; Chun-Wei Chang; Chiung-Mei Chen; Kuan-Hsing Chen; Chien-Hung Chang; Hsiu-Chuan Wu; Kuo-Hsuan Chang
Journal:  BMC Nephrol       Date:  2021-06-05       Impact factor: 2.388

3.  Severe proteinuria secondary to amyloidosis requiring bilateral renal artery embolization.

Authors:  Chun-Tung Yeh; Hsiuo-Shan Tseng; Wen-Sheng Liu; Szu-Yuan Li; Wu Chang Yang; Yee-Yung Ng
Journal:  Case Rep Nephrol Urol       Date:  2012-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.